Recent animal and clinical studies have reported that Tau pathology can spread in the brain and cause cognitive impairment without the accumulation of Aβ, which may be due to the speeded clearance rate of Aβ in the brain upon anti-Aβ treatment for AD [33]. Here, MAPT is linked to Cognitive impairment.